Syner-KINASE® (urokinase)

Product category 

Therapy area 

  • Renal
  • Oncology

Syner-KINASE® (urokinase) is licensed in Great Britain for the treatment of thrombosed catheters and systemic thromboembolic occlusive disease (diseases caused by blood clots).

Downloads: 

AttachmentSize
PDF icon Syner-KINASE® (urokinase) Patient Information Leaflet (PIL)97.13 KB
PDF icon Syner-KINASE® (urokinase) Summary of Product Characteristics (SPC)202.6 KB

Syner-KINASE® has a GB licence

Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. Adverse events should also be reported to Syner-Med (Pharmaceutical Products) Limited. Tel. +44 020 8655 6380

Leave us a message

CONTACT US

UK Office
Syner-Med (Pharmaceutical Products) Ltd.
Syner-Med House
120 High Street
Purley, Surrey
CR8 2AD, United Kingdom

Tel: +44 (0)20 8655 6380
E: mail@syner-med.com